| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.42 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |